This inventor holds 1 USPTO granted patent. Top assignee: Lg Chemical Ltd.. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: In-Chull Kim: Innovator in Ophthalmic Formulations
Introduction: In-Chull Kim is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of ophthalmology, particularly in the treatment of myopia. His innovative approach combines pharmacological agents with advanced formulation techniques.
Latest Patents: In-Chull Kim holds a patent for an ophthalmic formulation aimed at treating myopia. This formulation comprises a dopamine agonist and cyclodextrin or its derivative, combined with a pharmaceutically acceptable carrier. This innovative solution addresses a critical need in vision correction.
Career Highlights: In-Chull Kim is associated with LG Chemical Ltd., a leading company in the chemical industry. His work at LG Chemical Ltd. has allowed him to focus on developing cutting-edge solutions in ophthalmic care. His dedication to research and development has positioned him as a key player in his field.
Collaborations: Throughout his career, In-Chull Kim has collaborated with esteemed colleagues, including Yong-Hee Lee and Yun-Jeong Choi. These partnerships have fostered a collaborative environment that enhances innovation and drives research forward.
Conclusion: In-Chull Kim's contributions to ophthalmic formulations exemplify the impact of innovative thinking in healthcare. His work not only addresses myopia treatment but also showcases the importance of collaboration in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile